BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33667384)

  • 21. Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia.
    Chong PSY; Zhou J; Chooi JY; Chan ZL; Toh SHM; Tan TZ; Wee S; Gunaratne J; Zeng Q; Chng WJ
    Oncogene; 2019 Feb; 38(9):1508-1519. PubMed ID: 30305722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
    Li C; Xin H; Shi Y; Mu J
    Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
    Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
    J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia.
    Sakoda T; Kikushige Y; Miyamoto T; Irifune H; Harada T; Hatakeyama K; Kunisaki Y; Kato K; Akashi K
    Blood Adv; 2023 May; 7(10):2053-2065. PubMed ID: 36745103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome.
    Xu J; Suzuki M; Niwa Y; Hiraga J; Nagasaka T; Ito M; Nakamura S; Tomita A; Abe A; Kiyoi H; Kinoshita T; Naoe T
    Br J Haematol; 2008 Feb; 140(4):394-401. PubMed ID: 18217891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.
    Zhou J; Toh SH; Chan ZL; Quah JY; Chooi JY; Tan TZ; Chong PSY; Zeng Q; Chng WJ
    J Hematol Oncol; 2018 Mar; 11(1):36. PubMed ID: 29514683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia.
    Carvajal LA; Neriah DB; Senecal A; Benard L; Thiruthuvanathan V; Yatsenko T; Narayanagari SR; Wheat JC; Todorova TI; Mitchell K; Kenworthy C; Guerlavais V; Annis DA; Bartholdy B; Will B; Anampa JD; Mantzaris I; Aivado M; Singer RH; Coleman RA; Verma A; Steidl U
    Sci Transl Med; 2018 Apr; 10(436):. PubMed ID: 29643228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives.
    Wagstaff M; Coke B; Hodgkiss GR; Morgan RG
    Biosci Rep; 2022 Apr; 42(4):. PubMed ID: 35352805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX30 confers a tumor suppressive effect in acute myeloid leukemia through inactivation of Wnt/β-catenin signaling.
    Liu Y; Wang W; Li Y; Huang Y
    Mol Cell Probes; 2020 Aug; 52():101578. PubMed ID: 32334007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis.
    Dietrich PA; Yang C; Leung HH; Lynch JR; Gonzales E; Liu B; Haber M; Norris MD; Wang J; Wang JY
    Blood; 2014 Nov; 124(22):3284-94. PubMed ID: 25293777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts.
    Kode A; Manavalan JS; Mosialou I; Bhagat G; Rathinam CV; Luo N; Khiabanian H; Lee A; Murty VV; Friedman R; Brum A; Park D; Galili N; Mukherjee S; Teruya-Feldstein J; Raza A; Rabadan R; Berman E; Kousteni S
    Nature; 2014 Feb; 506(7487):240-4. PubMed ID: 24429522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.
    Wang Y; Krivtsov AV; Sinha AU; North TE; Goessling W; Feng Z; Zon LI; Armstrong SA
    Science; 2010 Mar; 327(5973):1650-3. PubMed ID: 20339075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
    Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
    Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
    Schinke C; Giricz O; Li W; Shastri A; Gordon S; Barreyro L; Bhagat T; Bhattacharyya S; Ramachandra N; Bartenstein M; Pellagatti A; Boultwood J; Wickrema A; Yu Y; Will B; Wei S; Steidl U; Verma A
    Blood; 2015 May; 125(20):3144-52. PubMed ID: 25810490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.
    Gandillet A; Park S; Lassailly F; Griessinger E; Vargaftig J; Filby A; Lister TA; Bonnet D
    Leukemia; 2011 May; 25(5):770-780. PubMed ID: 21339756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
    Chen L; Hu N; Wang C; Zhao H
    Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin.
    Morgan RG; Pearn L; Liddiard K; Pumford SL; Burnett AK; Tonks A; Darley RL
    Leukemia; 2013 Feb; 27(2):336-43. PubMed ID: 22858986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
    Li C; Gao Q; Wang M; Xin H
    J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canonical Wnt: a safeguard and threat for erythropoiesis.
    Krimpenfort RA; Nethe M
    Blood Adv; 2021 Sep; 5(18):3726-3735. PubMed ID: 34516644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.